Tinos Therapeutics, Inc. — Form D/A
Tinos Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2026-04-17. The offering totals $4.0M, of which $2.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-04-17
- Form: D/A
- Accession: 0002088485-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $2.3M
- Remaining: $1.8M
- Investors: 3
- Revenue range: Decline to Disclose
- SEC file number: 021-558952
Issuer
- Name: Tinos Therapeutics, Inc.
- CIK: 0002088485
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 700 MAIN STREET, CAMBRIDGE, MA, 02139
- Phone: 570-939-7415
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| David Karambizi | Related Person | Cambridge, MA |
| Anastasios Polimenakos | Related Person | Cambridge, MA |
| Nikolaos Tapinos | Related Person | Cambridge, MA |
| Nikolaos Tapinos | Director | Cambridge, MA |
| Nikolaos Tapinos | Executive Officer | Cambridge, MA |
| David Karambizi | Director | Cambridge, MA |
| David Karambizi | Executive Officer | Cambridge, MA |
| Anastasios Polimenakos | Director | Cambridge, MA |
Other filings by this issuer (1)
More